Display options
Cite
Aldigier JC, Meur YL, Brunel P. Protection of Renal Function with ACE Inhibitors: Experience with Benazepril. Clin Drug Investig. 1998;16(6):463-72doi: 10.2165/00044011-199816060-00006.
Aldigier, J. C., Meur, Y. L., & Brunel, P. (1998). Protection of Renal Function with ACE Inhibitors: Experience with Benazepril. Clinical drug investigation, 16(6), 463-72. https://doi.org/10.2165/00044011-199816060-00006
Aldigier, J C, et al. "Protection of Renal Function with ACE Inhibitors: Experience with Benazepril." Clinical drug investigation vol. 16,6 (1998): 463-72. doi: https://doi.org/10.2165/00044011-199816060-00006
Aldigier JC, Meur YL, Brunel P. Protection of Renal Function with ACE Inhibitors: Experience with Benazepril. Clin Drug Investig. 1998;16(6):463-72. doi: 10.2165/00044011-199816060-00006. PMID: 18370561.
Copy Download .nbib Format: NLM
Share it on

Clin Drug Investig. 1998;16(6):463-72. doi: 10.2165/00044011-199816060-00006.

Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.

Clinical drug investigation

J C Aldigier, Y L Meur, P Brunel

Affiliations

  1. Centre Hospitalier Régional Universitaire Dupuytren, Limoges, France.

PMID: 18370561 DOI: 10.2165/00044011-199816060-00006

Abstract

Research into progressive renal scarring has been closely linked over the last two decades with angiotensin II (AII). This has led to a better understanding of the mechanisms underlying the development of glomerulosclerosis and tubulointerstitial scarring. AII appears to play an important role in the pathogenesis of both; this may be because of either a direct proliferative and fibrogenic effect of AII or an indirect effect mediated by growth factors such as platelet-derived growth factor (PDGF) and transforming growth factor (TGF(beta1)). These findings have led to significant therapeutic advances as ACE inhibition prevents the progression of experimental renal scarring and attenuates the progression of chronic renal failure in humans. Benazepril, through its metabolite benazeprilat, is a non-sulfhydryl orally active ACE inhibitor. The kinetics of benazeprilat are substantially affected by severe renal impairment; for patients with a creatinine clearance of <30 ml/min the initial recommended daily dose is 5mg. The angiotensin converting enzyme inhibition in a progressive renal insufficiency (AIPRI) study confirmed that benazepril provides protection against the progression of renal insufficiency in patients with various renal diseases and that this treatment is well tolerated.

References

  1. J Am Soc Nephrol. 1995 Aug;6(2):224-33 - PubMed
  2. J Hypertens Suppl. 1994 Jul;12(4):S3-10 - PubMed
  3. Hypertension. 1990 Oct;16(4):452-61 - PubMed
  4. Am J Nephrol. 1987;7(6):421-33 - PubMed
  5. N Engl J Med. 1989 Sep 28;321(13):868-73 - PubMed
  6. Biochem J. 1995 Feb 1;305 ( Pt 3):777-84 - PubMed
  7. J Clin Invest. 1986 Jun;77(6):1993-2000 - PubMed
  8. Lancet. 1995 May 13;345(8959):1195-8 - PubMed
  9. J Clin Invest. 1985 Aug;76(2):612-9 - PubMed
  10. Scand J Clin Lab Invest. 1977 May;37(3):223-7 - PubMed
  11. Am Heart J. 1989 Mar;117(3):746-51 - PubMed
  12. Curr Opin Nephrol Hypertens. 1996 Nov;5(6):468-75 - PubMed
  13. Am J Physiol. 1987 Aug;253(2 Pt 2):F299-309 - PubMed
  14. J Am Soc Nephrol. 1995 Jul;6(1):95-101 - PubMed
  15. BMJ. 1992 Feb 8;304(6823):339-43 - PubMed
  16. Hypertension. 1992 May;19(5):464-74 - PubMed
  17. Kidney Int. 1991 Jul;40(1):107-14 - PubMed
  18. Ann Intern Med. 1993 Jan 15;118(2):129-38 - PubMed
  19. J Hypertens Suppl. 1988 Dec;6(3):S17-22 - PubMed
  20. J Clin Invest. 1992 Nov;90(5):1932-43 - PubMed
  21. Kidney Int. 1990 Jul;38(1):101-7 - PubMed
  22. J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):840-3 - PubMed
  23. J Biol Chem. 1992 Nov 15;267(32):23129-35 - PubMed
  24. Am J Hypertens. 1988 Jan;1(1):54-7 - PubMed
  25. J Clin Invest. 1988 Jul;82(1):322-30 - PubMed
  26. Diabete Metab. 1992 Jul-Aug;18(4):283-8 - PubMed
  27. Clin Nephrol. 1998 Aug;50(2):108-12 - PubMed
  28. Kidney Int Suppl. 1997 Dec;63:S63-6 - PubMed
  29. N Engl J Med. 1996 Jan 4;334(1):13-8 - PubMed
  30. Am J Physiol. 1981 Jul;241(1):F85-93 - PubMed
  31. Nephrol Dial Transplant. 1990;5(9):777-80 - PubMed
  32. Lancet. 1982 Dec 11;2(8311):1309-11 - PubMed
  33. Kidney Int. 1996 Feb;49(2):578-97 - PubMed
  34. Am J Physiol. 1990 Nov;259(5 Pt 2):F768-77 - PubMed
  35. Clin Pharmacol Ther. 1996 Oct;60(4):472-8 - PubMed
  36. Clin Exp Pharmacol Physiol. 1995 Aug;22(8):499-505 - PubMed
  37. J Chromatogr. 1987 Aug 7;419:123-33 - PubMed
  38. Biopharm Drug Dispos. 1989 Jul-Aug;10(4):365-76 - PubMed
  39. J Clin Invest. 1995 Aug;96(2):953-64 - PubMed
  40. Am J Kidney Dis. 1989 Oct;14(4):272-6 - PubMed
  41. J Clin Invest. 1990 Feb;85(2):541-9 - PubMed
  42. JAMA. 1994 Jan 26;271(4):275-9 - PubMed
  43. Am J Kidney Dis. 1995 Jan;25(1):107-12 - PubMed
  44. Nephrol Dial Transplant. 1995 Nov;10(11):1963-74 - PubMed
  45. Diabetes. 1997 Dec;46(12):1950-7 - PubMed
  46. N Engl J Med. 1993 Nov 11;329(20):1456-62 - PubMed
  47. Hypertension. 1993 Jan;21(1):29-35 - PubMed
  48. Kidney Int. 1994 Mar;45(3):861-7 - PubMed
  49. BMJ. 1994 Oct 1;309(6958):833-7 - PubMed
  50. N Engl J Med. 1996 Apr 11;334(15):939-45 - PubMed
  51. Am J Physiol. 1993 Jun;264(6 Pt 2):F937-42 - PubMed
  52. J Hypertens. 1990 Nov;8(11):991-5 - PubMed
  53. Nephrol Dial Transplant. 1993;8(9):808-13 - PubMed
  54. Hypertension. 1994 Feb;23(2):145-58; discussion 159-60 - PubMed
  55. Am J Pathol. 1992 Jan;140(1):95-107 - PubMed
  56. Diabetes. 1996 Jan;45 Suppl 1:S125-8 - PubMed
  57. Hypertension. 1993 Aug;22(2):188-96 - PubMed
  58. Circ Res. 1988 Apr;62(4):749-56 - PubMed
  59. Am J Physiol. 1988 Feb;254(2 Pt 2):F267-76 - PubMed
  60. Arzneimittelforschung. 1989 Jan;39(1):62-7 - PubMed
  61. J Exp Med. 1983 Dec 1;158(6):1836-52 - PubMed
  62. Nephrol Dial Transplant. 1995;10(5):643-7 - PubMed
  63. J Chromatogr. 1988 Mar 18;425(2):353-61 - PubMed
  64. J Cardiovasc Pharmacol. 1992 Sep;20(3):348-57 - PubMed
  65. Nephrol Dial Transplant. 1996 Jun;11(6):1003-11 - PubMed
  66. Circ Res. 1994 Nov;75(5):844-53 - PubMed
  67. J Clin Pharmacol. 1989 Jul;29(7):609-14 - PubMed
  68. Cell Regul. 1991 Mar;2(3):219-27 - PubMed
  69. Clin Sci (Lond). 1990 Jun;78(6):585-90 - PubMed
  70. Eur J Clin Pharmacol. 1993;44(5):463-6 - PubMed

Publication Types